Biotech | October 30, 2023
EnginZyme produces key mRNA vaccine ingredient using biocatalysis
2023 Nobel laureates discovered how pseudouridine could make mRNA suitable for vaccines
2023 Nobel laureates discovered how pseudouridine could make mRNA suitable for vaccines
Dr Reddy’s Laboratories recorded revenue of Rs 6,880.20 crore during the quarter
Approval based on DESTINY-Lung02 results where AstraZeneca and Daiichi Sankyo’s Enhertu demonstrated a confirmed objective response rate of 49% and median duration of response of 16.8 months in previously treated patients
The Responsible Export Organisation (REO) certification is a distinguished recognition awarded by the Confederation of Indian Industry (CII)
RHTC will address a long-standing healthcare access issue for all the local population
In the Phase 3 LIBRETTO-431 study, Retevmo more than doubled progression-free survival (PFS) compared to chemotherapy plus pembrolizumab in patients with advanced or metastatic rearranged during transfection (RET) fusion-positive non-small cell lung cancer (NSCLC)
Nanoform will receive access to compound libraries and large data sets to undertake STARMAP screening
Orgovyx is the first and only oral GnRH receptor antagonist approved for advanced prostate cancer in Canada
The company is confident of addressing all the observations within the stipulated time
Investment is additive to KKR’s existing health care growth strategy
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
